A model for predicting overall survival in men with metastatic castrate-resistant prostate cancer (CRPC) for whom first-line chemotherapy failed

被引：0
|
作者：
Halabi, Susan
Lin, Chen-Yen
Small, Eric Jay
Armstrong, Andrew J.
Kaplan, Ellen B.
Petrylak, Daniel Peter
Sternberg, Cora N.
Shen, Liji
Oudard, Stephane
De Bono, Johann Sebastian
Sartor, A. Oliver
机构：
[1] Duke Univ, Med Ctr, Durham, NC USA
[2] Duke Univ, Durham, NC USA
[3] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA
[4] Duke Univ, Div Med Oncol & Urol, Duke Canc Inst, Durham, NC USA
[5] Duke Univ, Div Med Oncol & Urol, Duke Prostate Ctr, Durham, NC USA
[6] Yale Univ, Smilow Canc Hosp, New Haven, CT USA
[7] San Camillo & Forlanini Hosp, Rome, Italy
[8] Sanofi, Malvern, PA USA
[9] Hop Europeen Georges Pompidou, Paris, France
[10] Inst Canc Res, London SW3 6JB, England
[11] Tulane Canc Ctr, New Orleans, LA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 06期
关键词：
D O I：
10.1200/jco.2013.31.6_suppl.24
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
24
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Use of crowdsourced research to develop a prognostic model for first-line metastatic castrate resistant prostate cancer (mCRPC).
    Zhou, Fang Liz
    Guinney, Justin
    Wang, Tao
    Bare, J. Christopher
    Norman, Thea C.
    Bot, Brian
    Shen, Liji
    Winner, Kimberly Kanigel
    Friend, Stephen Henry
    Abdallah, Kald
    Stolovitzky, Gustavo A.
    Xie, Yang
    Costello, James
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [42] Efficacy and toxicity of docetaxel in elderly men with castrate-resistant metastatic prostate cancer.
    Shepard, D. R.
    Weil, A.
    Garcia, J. A.
    Dreicer, R.
    Raghavan, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [43] Prognostic utility of FDG PET/CT in men with castrate-resistant metastatic prostate cancer
    Jadvar, Hossein
    Desai, Bhushan
    Ji, Lingyun
    Conti, Peter
    Dorff, Tanya
    Pinski, Jacek
    Quinn, David
    Groshen, Susan
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [44] Timing of docetaxel chemotherapy and impact on outcomes in metastatic castrate-resistant prostate cancer (MCRPC).
    Thomson, Alastair
    Pollard, Adam
    Mark, Frances May
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [45] Pain Response to Radium-223 in Men With Metastatic Castrate-Resistant Prostate Cancer
    Zhang, I.
    Gilbo, P.
    Cox, B. W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E530 - E530
  • [46] Overall survival (OS) prognostic factors in metastatic castrate-resistant prostate cancer (mCRPC) patients retreated with docetaxel (D)
    Shah, Shilpa Rashmikant
    Albany, Costantine
    Hahn, Noah M.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [47] Number of prescription drugs and overall survival in metastatic castrate resistant prostate cancer
    Schoen, Martin W.
    Pickett, Carley
    Eaton, Daniel B.
    Heiden, Brendan T.
    Chang, Su-Hsin
    Yan, Yan
    Subramanian, Melanie P.
    Puri, Varun
    CANCER RESEARCH, 2023, 83 (07)
  • [48] A novel intermediate endpoint for predicting overall survival in men with metastatic castration-recurrent prostate cancer (CRPC)
    Halabi, S.
    Ou, S.
    Vogelzang, N. J.
    Scher, H.
    Small, E. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [49] Survival outcomes for men with castrate-resistant prostate cancer (CRPC) treated with a dendritic-cell based vaccine in a randomized controlled trial
    Gardiner, R. A.
    Mactaggart, P.
    Yaxley, J.
    Nicol, D.
    Mcclintock, S.
    Ellem, K.
    Hart, D.
    Seymour, G. J.
    Lopez, A.
    Schmidt, C.
    BJU INTERNATIONAL, 2014, 113 : 34 - 35
  • [50] SURVIVAL OUTCOMES FOR MEN WITH CASTRATE-RESISTANT PROSTATE CANCER (CRPC) TREATED WITH A DENDRITIC-CELL BASED VACCINE IN A RANDOMIZED CONTROLLED TRIAL
    Gardiner, R. A.
    Mactaggart, P.
    Yaxley, J.
    Nicol, D.
    McClintock, S.
    Ellem, K. A. O.
    Hart, D.
    Seymour, G. J.
    Lopez, A.
    Schmidt, C.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 : 33 - 34
12345